2010
DOI: 10.1016/j.bmcl.2010.02.083
|View full text |Cite
|
Sign up to set email alerts
|

2,5-Disubstituted pyridines as potent GPR119 agonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
26
0
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(28 citation statements)
references
References 10 publications
1
26
0
1
Order By: Relevance
“…The clustering analysis of propan-2-yl 4-( [6-[4-(propane-1-sulfonyl)piperzin-1-yl]-oxy)methylpiperidine-1-carboxylate (Wu Compound 19A) resulted in the generation of three clusters (Cluster 36, Cluster 64, and Cluster 435) of which a representative fragment from each group is shown which are responsible for the activity of this compound ( Figure 5.3). The fragment analysis indicates that the sulfonamide and carbamate groups are important for Wu Compound 19A agonist activity, which is consistent with previously reported SAR of this compound (Wu et al, 2010).…”
Section: Analysis Of Compounds Not In the Training Setsupporting
confidence: 79%
See 2 more Smart Citations
“…The clustering analysis of propan-2-yl 4-( [6-[4-(propane-1-sulfonyl)piperzin-1-yl]-oxy)methylpiperidine-1-carboxylate (Wu Compound 19A) resulted in the generation of three clusters (Cluster 36, Cluster 64, and Cluster 435) of which a representative fragment from each group is shown which are responsible for the activity of this compound ( Figure 5.3). The fragment analysis indicates that the sulfonamide and carbamate groups are important for Wu Compound 19A agonist activity, which is consistent with previously reported SAR of this compound (Wu et al, 2010).…”
Section: Analysis Of Compounds Not In the Training Setsupporting
confidence: 79%
“…The 31 inactive compounds consisted of compounds which do act as agonists for GPR119 at concentrations up to 10 µM, which were experimentally confirmed using the established HTRF assay Recently, Wu et al 2010 synthesized a series of piperazinylpyridine derivatives as GPR119 agonists (Wu et al, 2010). Through SAR analysis, compounds with alkylsulfonamide and isopropylcarbamate end groups displayed potent GPR119 receptor activity (Wu et al, 2010). The clustering analysis of propan-2-yl 4-( [6-[4-(propane-1-sulfonyl)piperzin-1-yl]-oxy)methylpiperidine-1-carboxylate (Wu Compound 19A) resulted in the generation of three clusters (Cluster 36, Cluster 64, and Cluster 435) of which a representative fragment from each group is shown which are responsible for the activity of this compound ( Figure 5.3).…”
Section: Analysis Of Compounds Not In the Training Setmentioning
confidence: 98%
See 1 more Smart Citation
“…These analogs offered no significant improvement in FaSSIF solubility (3.4 mg/mL for 36), however, and the exposure of 36 after oral administration was low in preclinical species. 75,76 7.4.5 Merck and Co.…”
Section: Glaxosmithklinementioning
confidence: 99%
“…近期研究还发现该类化 合物可作为潜在的 GPR119 拮抗剂及消炎药物 [11,12] . 我们课题组开展了对多取代吡啶化合物的研究工作 [13,14] , 并设计合成了一系列含烷氨基或烷硫基的多 取代吡啶衍生物.本文以 6-烷硫基吡啶化合物为原料, Table 1 Herbicidal activity of title compounds (relative inhibition rate%)…”
Section: -[2-(叔丁基羰氧基)丁氧基]苯甲unclassified